Stay updated on Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2; no visible changes to the study details are evident.
    Difference
    0.1%
    Check dated 2026-03-06T17:46:13.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Investigator list updated: Kannan Thanikachalam, MD added and Renuka Iyer removed. Page revised to version 3.4.2 on 2026-02-05.
    Difference
    0.3%
    Check dated 2026-02-13T03:16:41.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new page revision tag was added: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:25:25.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated the QC status label to 'Last Update Submitted that Met QC Criteria' with capitalization adjustments; the revision tag is updated to v3.4.0. Capitalization changes are applied to 'No FEAR Act Data' (instead of 'No FEAR Act data').
    Difference
    0.2%
    Check dated 2026-01-29T06:45:59.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    In the Study Record Dates section, the timestamp label was changed from 'Last Update Posted (Estimated)' to 'Last Update Posted'. This is a minor UI/text change related to timestamp labeling.
    Difference
    0.1%
    Check dated 2026-01-22T04:22:12.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    A minor site revision was applied (v3.3.4) with no visible changes to the study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:26:16.000Z thumbnail image

Stay in the know with updates to Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib and Pembrolizumab in Liver Cancer Clinical Trial page.